Usefulness of laser, in the treatment of lichen planus

EFFICACY OF DIODE LASER AS AN ADJUNCT TO TOPICAL STEROIDS IN TREATMENT OF ORAL LICHEN PLANUS THROUGH THE EVALUATION OF SERUM TNF-Î?LPHA LEVEL â?? AN INTERVENTIONAL STUDY - DIODEOLP

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017341

Enrollment

Registered

2019-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

Intervention1: DIODE LASER: Zolar, Photon Plus 10 watt with 980nm diode versatility (FDA approved) Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years and above of both genders Patients diagnosed with OLP, based on WHO criteria

Exclusion criteria

Exclusion criteria: 1. Smokers and alcoholics 2. Dysplasia on histopathology 3. Lichenoid drug reactions & lichenoid contact reactions, differentiated through history & clinical examination. 4. Previously treated cases of Oral lichen planus. 5. Subjects on systemic steroid or other immunosuppressive drugs previously.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of diode laser as an adjuvant to topical steroids on serum tumor necrosis factor- Î±lpha (TNF-alpha) level in OLP patientsTimepoint: To evaluate the efficacy of diode laser as an adjuvant to topical steroids on serum tumor necrosis factor- alpha (TNF-alpha) level in OLP patients in 4 weeks	—

Secondary

Measure	Time frame
To evaluate reduction in pain, burning, size of the lesionTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Aravinda Konidena

Swami Devi Dyal Hospital and Dental College

karavinda1@gmail.com9915388939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026